Skip to main content
Pankaj Bhargava, MD, Oncology, Boston, MA

Pankaj Bhargava MD


Physician

Join to View Full Profile
  • 44 Binney StDanafarber Cancer InstituteBoston, MA 02115

  • Phone+1 617-632-6184

  • Fax+1 617-632-5370

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Pankaj Bhargava, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, California, and District of Columbia.

Education & Training

  • MedStart Georgetown University Hospital
    MedStart Georgetown University HospitalFellowship, Medical Oncology, 1995 - 1997
  • Maimonides Medical Center
    Maimonides Medical CenterResidency, Internal Medicine, 1992 - 1995
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1991

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1996 - Present
  • CA State Medical License
    CA State Medical License 2007 - 2026
  • MA State Medical License
    MA State Medical License 2000 - 2020
  • VA State Medical License
    VA State Medical License 1996 - 2018
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • MPM Capital Adds to Senior Team with the Appointment of Oncology Leader Pankaj Bhargava, MD as Executive Partner
    MPM Capital Adds to Senior Team with the Appointment of Oncology Leader Pankaj Bhargava, MD as Executive PartnerApril 13th, 2021
  • Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-PH1 in Patients with Primary Hyperoxaluria Type 1 (PH1)
    Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-PH1 in Patients with Primary Hyperoxaluria Type 1 (PH1)May 13th, 2016
  • Dicerna Pharmaceuticals Appoints Dr. Pankaj Bhargava as Chief Medical Officer
    Dicerna Pharmaceuticals Appoints Dr. Pankaj Bhargava as Chief Medical OfficerApril 2nd, 2014